Allelic loss on chromosome 9 in bladder cancer tissues and urine samples detected by blunt-end single-strand DNA conformation polymorphism

International Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 425-429

  Shigyo, Masanori ^a,b   Sugano, Kokichi ^a   Fukayama, Noriko ^a   Taniguchi, Takahiro ^a   Tobisu, Ken Ichi ^a   Fujimoto, Hiroyuki ^a   Doi, Naoto ^a   Niwakawa, Masashi ^a   Shimamura, Kayako ^a   Tsukamoto, Taiji ^b   Sekiya, Takao ^c   Kakizoe, Tadao ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CHROMOSOME 9; CLINICAL ARTICLE; GENE LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOMES, HUMAN, PAIR 9; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUCLEIC ACID CONFORMATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 0031726207     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981109)78:4<425::AID-IJC6>3.0.CO;2-W     Document Type: Article

References (20)

1. BROOKS, C.C. and TOLAN, D.R., Association of the widespread A149P hereditary fructose intolerance mutation with newly identified sequence polymorphism in the aldolase B gene. Amer. J. Hum. Genet., 52, 835-840 (1993).
2. CAIRNS, P., SHAW, M.E. and KNOWLES, M.A., Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene, 8, 1083-1085 (1993).
3. DALBAGNI, G., PRESTI, J., REUTER, V., FAIR, W.R. and CORDON-CARDO, C., Genetic alterations in bladder cancer. Lancet, 342, 469-471 (1993).
4. GANLY, P.S., JARAD, N., RUDD, R.M. and RABBITTS, PH., PCR-based RFLP analysis allows genotyping of the short arm of chromosome 3 in small biopsies from patients with lung cancer. Genomics, 12, 221-228 (1992).
5. HAHN, S.A., SEYMOUR, A.B., HOQUE, A.T.M.S., SCHUTTE, M., DA COSTA, L.T., REDSTON, M.S., CALDAS, C., WEINSTEIN, C.L., FISCHER, A., YEO, C.J., HRUBAN, R.H. and KERN, S.E., Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res., 55, 4670-4675 (1995).
6. KEEN, A.J. and KNOWLES, M.A., Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene, 9, 2083-2088 (1994).
7. KNOWLES, M.A., ELDER, P.A., WILLIAMSON, M., CAIRNS, J.P., SHAW, M.E. and LAW, M.G., Allelotype of human bladder cancer. Cancer Res., 54, 531-538 (1994).
8. MAO, L., SCHOENBERG, M.P., SCICCHITANO, M., EROZAN, Y.S., MERLO, A., SCHWAB, D. and SHIDRANSKY, D., Molecular detection of primary bladder cancer by microsatellite analysis. Science, 271, 659-662 (1996).
9. MATSUYAMA, H., BERGERHEIM, U.S.R., NILSSON, I., PAN, Y., SKOOG, L., TRIBUKAIT, B. and EKMAN, P., Nonrandom numerical aberrations of chromosomes 7, 9 and 10 in DNA-diploid bladder cancer. Cancer Genet. Cytogenet., 77, 118-124 (1994).
10. OLUMI, A.F., TSAI, Y.C., NICHOLS, P.W., SKINNER, D.G., CAIN, D.G., BENDER, L.I. and JONES, P.A., Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res., 50, 7081-7083 (1990).
11. ORLOW, I., LIANES, P., LACOMBE, L., DALBAGNI, G., REUTER, V.E. and CORDON-CARDO, C., Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res., 54, 2848-2851 (1994).
12. SIMONEAU, A.R., SPRUCK, C.H., III, GONZALES-ZULUETA, M., GONZALGO, M.L., CHAN, M.F., TSAI, Y.C., DEAN, M., STEVEN, K., HORN, T. and JONES, P.A., Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Cancer Res., 56, 5039-5043 (1996).
13. SPRUCK, C.H., III and 16 OTHERS, Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54, 784-788 (1994).
14. STEINER, G., SCHOENBERG, M.P., LINN, J.F., MAO. L. and SHIDRANSKY, D., Detection of bladder cancer recurrence by microsatellite analysis of urine. Nature Med., 3, 621-624 (1997).
15. SUGANO, K., KYOGOKU, A., FUKAYAMA, N., OHKURA, H., SHIMOSATO, Y., SEKIYA, T. and HAYASHI, K., Rapid and simple detection of c-Ki-ras2 gene codon 12 mutations by nonradioisotopic single-strand conformation polymorphism analysis. Lab. Invest., 68, 361-366 (1993).
16. SUGANO, K., NAKASHIMA, Y., YAMAGUCHI, K., FUKAYAMA, N., MAEKAWA, M., OHKURA, H., KAKIZOE, T. and SEKIYA, T., Sensitive detection of loss of heterozygosity in the Tp53 gene in pancreatic adenocarcinoma by fluorescence-based single-strand conformation polymorphism analysis using blunt-end DNA fragments. Genes Chromosomes Cancer 15, 157-164 (1996).
17. SUGANO, K., TSUTSUMT, M., NAKASHIMA, Y., YAMAGUCHI. K., OHKURA, H., KAKIZOE, T. and SEKIYA, T., Diagnosis of bladder cancer by analysis of the allelic loss of the p53 gene in urine samples using blunt-end single-strand conformation polymorphism. Int. J. Cancer, 74, 403-406 (1997).
18. TSUTSUMI, M. SUGANO, K., YAMAGUCHI. K., KAKIZOE, T. and AKAZA, H., Correlation of allelic loss of the p53 gene and tumor grade, stage and malignant progression in bladder cancer. Int. J. Urol., 4, 74-78 (1997).
19. UICC, TNM classification of malignant tumours. Springer. Berlin (1987).
20. YAMAGUCHI, K., SUGANO, K., FUKAYAMA, N., NAKASHIMA, Y., SAOTOME, K., YOKOYAMA, T., YOKOTA, T. and OHKURA, H., Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms. Amer. J. Gastroenterol., 92, 307-312 (1997).